Search results
Results from the WOW.Com Content Network
In the cancer disease state, the interaction of PD-L1 on the tumor cells with PD-1 on a T-cell reduces T-cell function signals to prevent the immune system from attacking the tumor cells. [9] Use of an inhibitor that blocks the interaction of PD-L1 with the PD-1 receptor can prevent the cancer from evading the immune system in this way. [9]
29126 60533 Ensembl ENSG00000120217 ENSMUSG00000016496 UniProt Q9NZQ7 Q9EP73 RefSeq (mRNA) NM_001314029 NM_001267706 NM_014143 NM_021893 RefSeq (protein) NP_001254635 NP_001300958 NP_054862 NP_068693 Location (UCSC) Chr 9: 5.45 – 5.47 Mb Chr 19: 29.34 – 29.37 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation ...
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. [5] [6] [10] Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.
The company expects the largest advantage in patients with lower levels of PDL1, the protein targeted by Keytruda, and plans to launch a Phase 3 trial enrolling only those patients by the end of ...
People have had severe infusion-related reactions to pembrolizumab. There have also been severe immune-related adverse effects including lung inflammation (including fatal cases) and inflammation of endocrine organs that caused inflammation of the pituitary gland, of the thyroid (causing both hypothyroidism and hyperthyroidism in different people), and pancreatitis that caused Type 1 diabetes ...
Programmed cell death protein 1 (PD-1), (CD279 cluster of differentiation 279). PD-1 is a protein encoded in humans by the PDCD1 gene. [5] [6] PD-1 is a cell surface receptor on T cells and B cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity.
The Houston Fire Department serves areas of Clear Lake City within the City of Houston limits. In 1978, City of Houston officials contracted with the Lyndon B. Johnson Space Center to open a fire station on the base. [17] The city introduced plans to provide services for the Pipers Meadow area, which was annexed in 1994.
The US Food and Drug Administration (FDA) approved it in March 2017, for the treatment of Merkel-cell carcinoma, [7] an aggressive type of skin cancer. The EMA approved it in September 2017, for the same indication. [9] This is the first FDA-approved treatment for metastatic Merkel-cell carcinoma, a rare, aggressive form of skin cancer. [7]